Success Metrics

Clinical Success Rate
80.0%

Based on 8 completed trials

Completion Rate
80%(8/10)
Active Trials
2(17%)
Results Posted
25%(2 trials)
Terminated
2(17%)

Phase Distribution

Ph phase_4
2
17%
Ph not_applicable
2
17%
Ph phase_1
3
25%
Ph phase_2
2
17%
Ph phase_3
2
17%

Phase Distribution

3

Early Stage

2

Mid Stage

4

Late Stage

Phase Distribution11 total trials
Phase 1Safety & dosage
3(27.3%)
Phase 2Efficacy & side effects
2(18.2%)
Phase 3Large-scale testing
2(18.2%)
Phase 4Post-market surveillance
2(18.2%)
N/ANon-phased studies
2(18.2%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

80.0%

8 of 10 finished

Non-Completion Rate

20.0%

2 ended early

Currently Active

2

trials recruiting

Total Trials

12

all time

Status Distribution
Active(2)
Completed(8)
Terminated(2)

Detailed Status

Completed8
Terminated2
Recruiting2

Development Timeline

Analytics

Development Status

Total Trials
12
Active
2
Success Rate
80.0%
Most Advanced
Phase 4

Trials by Phase

Phase 13 (27.3%)
Phase 22 (18.2%)
Phase 32 (18.2%)
Phase 42 (18.2%)
N/A2 (18.2%)

Trials by Status

terminated217%
recruiting217%
completed867%

Recent Activity

2 active trials
Showing 5 of 12
recruitingphase_3

Benefits of ADHD Treatment in Detained People

NCT05842330
recruitingnot_applicable

Neurofeedback-Based Digital Therapeutics for the Diagnosis and Treatment of ADHD in Children.

NCT06369714
completedphase_1

Biomarkers of ADHD Treatment Response

NCT05650775
completedphase_4

Efficacy of Concerta in Treating ADHD in Mothers of Children With ADHD

NCT00318981
terminatedphase_4

Real-World Evidence of Duration of Effect of Adhansia XR (Extended-Release) for Treatment of Attention-Deficit/Hyperactivity Disorder (ADHD)

NCT04507204
View all 12 trials

Clinical Trials (12)

Showing 12 of 12 trials
NCT05842330Phase 3

Benefits of ADHD Treatment in Detained People

Recruiting
NCT06369714Not Applicable

Neurofeedback-Based Digital Therapeutics for the Diagnosis and Treatment of ADHD in Children.

Recruiting
NCT05650775Phase 1

Biomarkers of ADHD Treatment Response

Completed
NCT00318981Phase 4

Efficacy of Concerta in Treating ADHD in Mothers of Children With ADHD

Completed
NCT04507204Phase 4

Real-World Evidence of Duration of Effect of Adhansia XR (Extended-Release) for Treatment of Attention-Deficit/Hyperactivity Disorder (ADHD)

Terminated
NCT04647500Not Applicable

Effects of Methylphenidate on Brain and Cognition in 22q11 Deletion Syndrome

Completed
NCT00901576Phase 1

A Drug Interaction Study of SPD503 and Concerta Administered Alone and In Combination in Normal Healthy Volunteers

Completed
NCT02730572

Concerta (Methylphenidate) -To-Generic Switch Study

Completed
NCT00151970Phase 2

Efficacy, Safety and Tolerability of SPD485 in Children Aged 6-12 Diagnosed With ADHD

Completed
NCT00444574Phase 3

Safety and Efficacy of MTS Versus Concerta in Pediatric Patients (Aged 6-12 Years) With ADHD

Completed
NCT00069927Phase 2

Adderall XR Compared With Concerta in Treating Young Cancer Patients With Memory, Attention, and Depression

Terminated
NCT01118702Phase 1

A Study to Explore Plasma Levels of CONCERTA, Ritalin-SR and Novo-Methylphenidate ER-C in Healthy Volunteers

Completed

All 12 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
12